Novartis Investigative Site

Lille, France 59 037

0 studies enrolling now · 1 studies all time

What they study most

Hodgkin's Lymphoma

Studies at this site

• A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL) — Completed